Only three drugs Novo Nordisks Wegovy and Saxenda, and Eli Lillys Zepbound are actually approved for that purpose
Clinical Core Core Directors: Joseph Dillon, MD Muhammad Furqan, MD The overarching goal of the Clinical Core is to serve as a bidirectional link between patients with neuroendocrine tumor (NET) or neuroendocrine carcinoma (NEC) and advances in research, diagnosis, treatment, long-term care, and, ultimately, disease prevention
The Selank+Semax Nasal Spray ($55.99) delivers both nootropic peptides in a ready-to-use spray cognitive support without any reconstitution or injection
Neutrophil elastase: path clearer, pathogen killer, or just pathologic
The risks of taking the drug, including suicidal ideation, are too high
Weight-based calculations provide starting estimates that may improve response consistency across different body sizes